TARDBP and frontotemporal dementia: Although the complete elimination of TDP-43 is probably not appropriate because of its importance in cellular activities,12,13,14 lowering the level of TDP-43 is expected to be a potential disease-modifying therapeutic strategy to prevent the onset of or to delay the progression of ALS/FTD.15